<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0117">
 <label>117</label>
 <element-citation publication-type="journal" id="sbref0116">
  <person-group person-group-type="author">
   <name>
    <surname>Byrn</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Jones</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Bennett</surname>
    <given-names>H.B.</given-names>
   </name>
  </person-group>
  <article-title>Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit</article-title>
  <source>Antimicrob Agents Ch.</source>
  <volume>59</volume>
  <year>2015</year>
  <fpage>1574</fpage>
  <lpage>1587</lpage>
 </element-citation>
</ref>
